According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...

While the rising costs of health benefits pose challenges, ensuring employees have access to quality care is paramount." ...

Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest ...

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will ...

The COVID pandemic set in motion trends with alcohol use that have persisted. Disruptions in work, school and lifestyle have ...

Novo Nordisk's blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

Health Editor Amy Packer asks the medical experts to answer your most common questions about Ozempic, Mounjaro and Wegovy ...

Shirleyann Metcalfe, 64, told i she was almost instantly approved for online pharmacist Voy’s GLP1 weight-loss programme – ...

Weight loss drugs like Ozempic and Wegovy have gained popularity for their ability to help users shed pounds, but medical ...